Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy.
Richards M, García-De La Torre I, González-Bello YC, Vázquez-Del Mercado M, Andrade-Ortega L, Medrano-Ramírez G, Navarro-Zarza JE, Maradiaga-Ceceña M, Loyo E, Rojo-Mejía A, Gómez G, Seaman A, Fritzler MJ, Koenig M, Mahler M.
Richards M, et al. Among authors: koenig m.
Rheumatology (Oxford). 2019 Sep 1;58(9):1655-1661. doi: 10.1093/rheumatology/kez092.
Rheumatology (Oxford). 2019.
PMID: 30938432
Review.
CONCLUSION: Overall, good agreement was found between LIA and PMAT for anti-Mi-2 antibodies, which is important for the standardization of autoantibodies. Anti-Mi-2beta antibodies measured by PMAT tend be more highly associated with the clinical phenotype of DM....
CONCLUSION: Overall, good agreement was found between LIA and PMAT for anti-Mi-2 antibodies, which is important for the standardization of …